JMP Securities Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price
Haemonetics (NYSE:HAE – Free Report) had its price objective decreased by JMP Securities from $125.00 to $100.00 in a research note released on Friday morning,Benzinga reports. JMP Securities currently has a market outperform rating on the medical instruments supplier’s stock. Other analysts have also issued research reports about the company. JPMorgan Chase & Co. initiated […]
Haemonetics (NYSE:HAE – Free Report) had its price objective decreased by JMP Securities from $125.00 to $100.00 in a research note released on Friday morning,Benzinga reports. JMP Securities currently has a market outperform rating on the medical instruments supplier’s stock. Other analysts have also issued research reports about the company. JPMorgan Chase & Co. initiated […]
